Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Sep;5(3):262-5.
doi: 10.4103/0974-1208.106338.

Clomiphene citrate or letrozole as first-line ovulation induction drug in infertile PCOS women: A prospective randomized trial

Sujata Kar  1
Affiliations

Clomiphene citrate or letrozole as first-line ovulation induction drug in infertile PCOS women: A prospective randomized trial

Sujata Kar. J Hum Reprod Sci. 2012 Sep.

Abstract

Objective: To compare Letrozole (5 mg) and clomiphene citrate (100 mg) as first line ovulation induction drug in infertile PCOS women.

Study design: Prospective Randomised trial.

Setting: A Tertiary level infertility centre.

Patients: 103 infertile PCOS women.

Interventions: Treatment naïve infertile PCOS women were randomised to treatment with 5 mg letrozole (51 patients) or 100 mg clomiphene citrate (52 patients) daily starting day 2 to day 6 of menstrual cycle. Timed intercourse or Intra Uterine Insemination (IUI) was advised 24 to 36 hours after Human Chorionic Gonadotropin (HCG) injection.

Main outcome measures: Ovulation rate, mono or multi follicular rate, days to ovulation, endometrial thickness, serum progesterone, serum estrogen, pregnancy rate, miscarriage rate.

Results: The mean age, Body Mass Index (BMI), duration of infertility in both Clomiphene Citrate (CC) and Letrozole groups were similar.Ovulation rate was 73.08% in letrozole group and 60.78% in CC, which was not statistically significant (P=0.398). There was no statistically significant difference between Endometrial thickness (CC 7.61 ±1.96, Let 7.65 ± 2.10), Sr E2 on day of HCG (CC 178.3 ± 94.15, Let 162.09 ± 73.24), Days to ovulation (CC 14.2 ± 3.41; Let 13.13 ± 2.99) and Sr P4 on D21 (CC 10.58 ± 6.65; Let 11.86 ± 6.51). Monofolliculo genesis (CC 54.84, Let 79.49 %, P=0.027) and Pregnancy rate (CC 7.84%, Let 21.56% P=0.0125) were statistically significantly higher in letrozole group.

Conclusion: Our study shows that letrozole has excellent pregnancy rates compared to clomiphene citrate. Letrozole should be considered at par with clomiphene citrate as first line drug for ovulation induction in infertile PCOS women.

Keywords: Clomiphene citrate; PCOS; letrozole; ovulation induction.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared

References

    1. Kovacs G, Wood C. The current status of polycystic ovary syndrome. Aust N Z J Obstet Gynaecol. 2001;41:65–8. - PubMed
    1. Guzick D. Polycystic ovary syndrome, symptolatology, pathophysiology and epidemiology. Am J Obstet Gynecol. 1998;179:89–93. - PubMed
    1. Slowey MJ. Polycystic ovary syndrome: New perspective on an old problem. South Med J. 2001;94:190–5. - PubMed
    1. Casper RF. Letrozole versus clomiphene citrate: Which is better for ovulation induction? Fertil Steril. 2009;92:858–9. - PubMed
    1. Amsterdam ESHRE/ASRM – Sponsored 3rd PCOS consensus workshop Group. Consensus on women's health aspects of polycystic ovary syndrome (PCOS) Hum Reprod. 2012;27:14–24. - PubMed